Panacea Biotec Limited
PANACEABIO.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.21B
Close$
Share Statistics
| Market cap | $21.21 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.88 |
| Beta | 0.14 |
| Outstanding Shares | 61,250,746 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -297.63 |
|---|---|
| PEG | 688.8 |
| Price to Sales | 3.21 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Panacea Biotec Limited
2,102 employees
CEO: Rajesh Jain Panacea Biotec Limited, an Indian biotechnology firm, specializes in the full spectrum of activities for pharmaceutical formulations and vaccines, including research, development, manufacturing, and marketing. The company operates throug...